Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules

Respirology. 2023 Jun;28(6):582-584. doi: 10.1111/resp.14502. Epub 2023 Apr 5.

Authors

Roger Y Kim¹, Jason L Oke², Travis L Dotson³, Christina R Bellinger³, Anil Vachani¹

Affiliations

¹ Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
³ Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

PMID: 37017091
DOI: 10.1111/resp.14502

No abstract available

Keywords: artificial intelligence; clinical decision-making; lung neoplasms; risk assessment.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Artificial Intelligence
Humans
Lung Neoplasms* / diagnosis
Lung Neoplasms* / therapy
Multiple Pulmonary Nodules* / diagnostic imaging
Multiple Pulmonary Nodules* / therapy

Grants and funding